Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

AM-Pharma reports phase I data for recombinant human alkaline phosphatase

March 31, 2014

Enrollment begins in phase III study of ZS-9 in patients with hyperkalemia

March 28, 2014

Dimerix Bioscience raises funds to advance DMX-200

March 28, 2014

Samsca approved in Japan for autosomal dominant polycystic kidney disease

March 26, 2014

Ipsen reports findings from phase IIa study of Dysport for neurogenic detrusor overactivity

March 19, 2014

Novel spirocyclic diamine derivatives with activity in animal models of CKD

March 17, 2014

World Kidney Day: Early diagnosis and more accessible solutions for chronic kidney disease

March 13, 2014

Topline results released from phase II study of GCS-100 for chronic kidney disease

March 11, 2014

Fibrotech completes phase Ia study of FT-011 for diabetic nephropathy

March 10, 2014

Cumberland Pharmaceuticals acquires drug for hyponatremia

March 4, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.